Comparative risk and impact assessment for occupational and environmental health
Keywords:
quality of life (QOL), quality-adjusted life year (QALY), disability-adjusted life year (DALY), health risk/impact assessment, occupational health, environmental healthAbstract
In the quantification of burdens of diseases, QALY (quality-adjusted life year) or DALY (disability-adjusted life year) have been used for comparative assessment of population health. By adjusting the survival function with the mean of quality of life (QOL) at every time point t and summing up yearly throughout lifetime, we obtained the quality-adjusted life expectancy (QALE) with the unit of QALY:
QALE = òE[Qol(túxi)]S(túxi)dt
Three environmental health issues were empirically assessed as examples: the contamination of underground water by chlorinated hydrocarbons from an electronics factory; the enforcement of helmet law in Taipei city; and occupational policies for protection of offspring of female lead workers. The likelihoods and expected numbers of new cases with liver cancer, head injury, or mentally impaired offspring born to mothers of lead workers were estimated, and these were then multiplied by the quality-adjusted life expectancy lost per case. The results showed that the ground water pollution produced a potential loss of 78 QALM (quality-adjusted life month) for the 1000 people in the downstream community. The enforcement of helmet law in Taipei would save 6240 QALY annually. The expected utility loss of the babies born to female lead workers was about 216 QALY. If the QOL was measured by psychometry, it could be applied in clinical outcome evaluation. If it was extended to consider the cost of illness, the financial burden to the National Health Insurance could be estimated. We conclude that this is a feasible method for comparative health risk/impact assessment for public health and clinical policy decisions.
Downloads
Published
Issue
Section
License
OPEN ACCESS
All the articles of the European Journal of Oncology and Environmental Health are published with open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0 http://creativecommons.org/licenses/by/4.0/). This means that the author(s) retain copyright, but the content is free to download, distribute and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article.
The articles in the previous edition of the Journal (European Journal of Oncology) are made available online with open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0 http://creativecommons.org/licenses/by/4.0/).
Upon submission, author(s) grant the Journal the license to publish their original unpublished work within one year, and the non exclusive right to display, store, copy and reuse the content. The CC-BY Creative Commons attribution license enables anyone to use the publication freely, given appropriate attribution to the author(s) and citing the Journal as the original publisher. The CC-BY Creative Commons attribution license does not apply to third-party materials that display a copyright notice to prohibit copying. Unless the third-party content is also subject to a CC-BY Creative Commons attribution license, or an equally permissive license, the author(s) must comply with any third-party copyright notices.